Robert A Stewart's Net Worth

$19 Million

Estimate Recalculated May 20, 2024 03:13PM EST

Who is Robert A Stewart?

Robert A Stewart has an estimated net worth of $19 Million. This is based on reported shares across multiple companies, which include Amneal Pharmaceuticals, Inc., Allergan plc, Actavis, Inc., and CorMedix Inc..

SEC CIK

Robert A Stewart's CIK is 0001476493

Past Insider Trading and Trends

2013 was Robert A Stewart's most active year for acquiring shares with 6 total transactions. Robert A Stewart's most active month to acquire stocks was the month of February. 2013 was Robert A Stewart's most active year for disposing of shares, totalling 9 transactions. Robert A Stewart's most active month to dispose stocks was the month of February. 2013 saw Robert A Stewart paying a total of $6,514,500.00 for 281,699 shares, this is the most they've acquired in one year. In 2013 Robert A Stewart cashed out on 332,165 shares for a total of $26,809,680.74, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Amneal Pharmaceuticals, Inc. (AMRX) Snapshot price: $5.365

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+362.75%
61.67K
$13.44
-$290,424.96
78.67K
May 7
Form 4
∞
17K
$11.92
$202,640.00
17K
Mar 12
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
May 7
Form 3
—
0
—
—
0
No matching records found

Allergan plc No price found

Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.12%
-2.15K
$163.58
-$351,533.42
66.65K
Dec 29
Form 4
+22.04%
12.43K
—
—
68.8K
Oct 26
Form 4
+15.02%
7.36K
$237.68
$1,749,800.16
56.37K
Apr 3
Form 4
-1.53%
-761.00
$245.63
-$186,924.43
49.01K
Mar 5
Form 4
+3.26%
1.57K
$229.32
$360,261.72
49.77K
Feb 1
Form 4
+7.98%
3.56K
$295.70
-$296,882.80
48.2K
Mar 5
Form 4
—
0
—
—
0
Jul 1
Form 4
+8.20%
3.38K
$197.05
$666,620.15
44.64K
May 9
Form 4
-16.24%
-8.00K
$166.02
-$1,328,160.00
41.25K
Dec 9
Form 4
-16.88%
-10.00K
$164.44
-$1,644,400.00
49.25K
Nov 15
Form 4
-16.84%
-12.00K
$158.39
-$1,900,680.00
59.25K
Nov 11
Form 4
∞
71.25K
—
—
71.25K
Oct 1
Form 3
—
0
—
—
0
No matching records found

Actavis, Inc. No price found

Pres-Global Operations

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-73.89K
$115.43
—
0
Sep 30 - Oct 1
Form 4/A
-16.46%
-14.56K
$136.02
-$1,980,998.19
73.89K
Aug 2
Form 4
-16.46%
-14.56K
$136.02
-$1,980,998.19
73.89K
Aug 2
Form 4
+22.31%
16.14K
—
—
88.45K
Mar 6
Form 4
-6.27%
-4.83K
$85.54
-$413,500.36
72.32K
Mar 2
Form 4
+23.23%
14.54K
—
—
77.15K
Oct 31
Form 4
+45.26%
19.51K
—
—
62.61K
Mar 8
Form 4
-3.67%
-1.64K
$58.17
-$95,398.80
43.1K
Feb 24
Form 4
-3.50%
-1.62K
$64.52
-$104,651.44
44.74K
Nov 16
Form 4
+44.89%
14.37K
—
—
46.37K
Mar 2
Form 4
+45.45%
10K
—
—
32K
Feb 24
Form 4
∞
22K
—
—
22K
Nov 16
Form 3
—
0
—
—
0
No matching records found

CorMedix Inc. (CRMD) Snapshot price: $3

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 5
Form 4/A
+1,000.00%
10K
$4.37
$43,735.00
11K
May 17
Form 4
+1,000.00%
10K
$4.37
$43,735.00
11K
May 17
Form 4
—
0
—
—
0
Apr 13
Form 3
—
0
—
—
0
No matching records found